Left Ventricular Dysfunction: Clinical Trials

1 trial for Left Ventricular Dysfunction, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Recruiting 1

Follow Left Ventricular Dysfunction: new trials by email Literature Review of Left Ventricular Dysfunction trials Research Report on Left Ventricular Dysfunction

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
DAPAgliflozine to Attenuate Cardiac RemOdeling afTEr aCuTe myOcardial Infarction
Dapagliflozin propanediol (FORXIGA™/FARXIGA™1), Placebo comparator - AMI, STEMI
Phase 3RecruitingAssistance Publique - Hôpitaux de Paris4502023-06-122025-12-19

Narrower conditions

Non-ST Elevated Myocardial Infarction (1)  ·  ST Elevation Myocardial Infarction (1)  ·  Ventricular Dysfunction, Left (1)

Broader conditions

Cardiovascular Diseases (1)  ·  Heart Diseases (1)  ·  Infarction (1)  ·  Ischemia (1)  ·  Myocardial Infarction (1)  ·  Myocardial Ischemia (1)  ·  Necrosis (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Vascular Diseases (1)  ·  Ventricular Dysfunction (1)

Interventions

dapagliflozin (1)

Sponsors

Assistance Publique - Hôpitaux de Paris (1)

Countries

France (1)